Actions of insulin on the mammalian heart: Metabolism, pathology and biochemical mechanisms

Cardiovascular Research

Volumn 34, Issue 1, 1997, Pages 3-24

  Brownsey, Roger W ^a   Boone, Adrienne N ^a   Allard, Michael F ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Diabetes; Glucose transport; Insulin; Myocardial metabolism; Signal transduction

Indexed keywords

FATTY ACID; GLUCOSE; GLYCOGEN; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; PYRUVATE DEHYDROGENASE COMPLEX; RAS PROTEIN;

CYTOSKELETON; DIABETES MELLITUS; ENERGY METABOLISM; FATTY ACID METABOLISM; GENE EXPRESSION; GLUCOSE TRANSPORT; GLYCOGEN METABOLISM; GLYCOLYSIS; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HORMONE BINDING; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOMEGALY; GLUCOSE; HUMANS; HYPERTENSION; INSULIN; INTRACELLULAR FLUID; MAMMALS; MYOCARDIUM; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

EID: 0030900355     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00051-5     Document Type: Review

References (263)

1. Cheatham B, Kahn CR. Insulin action and the insulin signaling network. Endocr Rev 1995;16:117-142.
2. Cohen P. Dissection of the protein phosphorylation cascades involved in insulin and growth factor action. Biochem Soc Trans 1993;1:555-567.
3. Lawrence JC. Signal transduction and protein phosphorylation in the regulation of cellular metabolism by insulin. Annu Rev Physiol 1992;54:177-193.
4. Lee J, Pilch PF. The insulin receptor. Structure, function, and signaling. Am J Physiol 1994;266:C319-C334.
5. Williams A. Mitochondria. In: Drake-Holland AJ, Noble MIM, eds. Cardiac Metabolism. New York: John Wiley and Sons, 1983:151.
6. Denton RM. Early events in insulin action. Adv Cyclic Nucleotide Protein Phosphorylation Res 1986;20:289-336.
7. Rasmussen H. The calcium messenger system. N Engl J Med 1986;314:1094-1101,1164-1170.
8. Exton JH. Some thoughts on the mechanism of action of insulin. Diabetes 1991;40:521-526.
9. Jacobowitz D, Cooper T, Barner HB. Histochemical and chemical studies of the localization of adrenergic and cholinergic nerves in normal and denervated cat hearts. Circ Res 1967;20:289-298.
10. Sparks HV, Bardenheuer H. Regulation of adenosine formation by the heart. Circ Res 1986;58:193-201.
11. Finegan BA, Clanachan AS, Coulson CS, Lopaschuk GD. Adenosine modification of energy substrate use in isolated hearts perfused with fatty acids. Am J Physiol 1992;262:H1501-H1507.
12. Drewett JG, Garbers DL. The family of guanylyl cyclase receptors and their ligands. Endocr Rev 1994;15:135-162.
13. Kishimoto I, Dubois SK, Garbers DL. The heart communicates with the kidney exclusively through the guanylyl cyclase-A receptor - acute handling of sodium and water in response to volume expansion. Proc Natl Acad Sci USA 1996;93:6215-6219.
14. Baron AD. Hemodynamic actions of insulin. Am J Physiol 1994;267:E187-E202.
15. Kelly RA, Balligand J-L, Smith TW. Nitric oxide and cardiac function. Circ Res 1996;79:363-380.
16. Cahill GF. Physiology of insulin in man. Diabetes 1971;20:785-799.
17. Kimball SR, Vary TC, Jefferson LS. Regulation of protein synthesis by insulin. Annu Rev Physiol 1994;56:321-348.
18. Beutler B, Cerami A. Cachectin: more than a tumor necrosis factor. N Engl J Med 1987;316:379-385.
19. Randle PJ, Hales CN, Garland PB, Newsholme EA. The glucose fatty acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963;1:785-789.
20. Randle PJ, Garland PB, Hales CN, et al. Interactions of metabolism and the physiological role of insulin. Recent Prog Hormone Res 1966;22:1-44.
21. Dashti N, Wofbauer G. Secretion of lipids, apolipoproteins and lipoproteins by human hepatoma cell line, HepG2: effects of oleic acid and insulin. J Lipid Res 1987;28:423-426.
22. Lewis GF, Uffelman KD, Szeto LW, Weller B, Steiner G. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest 1995;95:158-166.
23. Bjorensztajn J, Otway S, Robinson DS. Effect of fasting on the clearing factor lipase (lipoprotein lipase) activity of defatted preparations of rat heart muscle. J Lipid Res 1970;11:102-110.
24. Bjorensztajn J, Robinson DS. The effect of fasting on the utilization of chylomicron triglyceride fatty acids in relation to clearing factor lipase (lipoprotein lipase) releasable by heparin in the perfused rat heart. J Lipid Res 1970;11:111-117.
25. Deshaies Y, Geloen A, Paulin A, Bukowieki LJ. Restoration of lipoprotein lipase activity in insulin-deficient rats by insulin infusion is tissue-specific. Can J Physiol Pharmacol 1991;69:746-751.
26. Cahill GF, Herrerra MG, Morgan AP, Soeldner JS, et al. Hormone-fuel interrelationships during fasting. J Clin Invest 1966;45:1751-1769.
27. Satoh K, Kashiwaya Y, Keon CA, et al. Insulin, ketones, and mitochondrial energy transduction. FASEB J 1995;9:651-658.
28. Lebovitz HE. Diabetic ketoacidosis. Lancet 1995;345:767-772.
29. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 1994;94:1171-1179.
30. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
31. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995;75:473-486.
32. Ogihara T, Rakugi H, Ikegami H, Mikami H, Masuo K. Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives. Am J Hypertens 1995;8:316-320.
33. Buchanan TA, Meehan WP, Jeng YY, et al. Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect. J Clin Invest 1995;96:354-360.
34. Davidson MB. Clinical implications of insulin resistance syndromes. Am J Med 1995;99:420-426.
35. Stern MP. Diabetes and cardiovascular disease: the 'common soil' hypothesis. Diabetes 1995;44:369-374.
36. Opie LH, Mansford KRL, Owen P. Effects of increased heart work on glycolysis and adenine nucleotides in the perfused heart of normal and diabetic rats. Biochem J 1971;124:475-490.
37. Neely JR, Whitmer KM, Mochizuki S. Effects of mechanical activity and hormones on myocardial glucose and fatty acid utilization. Circ Res 1976;38:I22-I30.
38. Lopaschuk GD, Belke DD, Gamble J, Itoi T, Schonekess BO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1994;1213:263-276.
39. Shipp JC, Opie LH, Challoner DR. Fatty acid and glucose metabolism in the perfused heart. Nature 1961;189:1018-1019.
40. Newsholme EA, Randle PJ, Manchester KL. Inhibition of the phosphofructokinase reaction in perfused rat heart by respiration of ketone bodies, fatty acids and pyruvate. Nature 1962;193:270-271.
41. Williamson JR, Krebs HA. Acetoacetate as fuel of respiration in the perfused rat heart . Biochem J 1961;80:540-547.
42. Lassers RW, Kaijser L, Wahlquist ML, Carlson LA. Relationship in man between plasma free fatty acids and myocardial metabolism of carbohydrate substrates. Lancet 1971;2:448-450.
43. McAllister A, Allison SP, Randle PJ. Effects of dichloroacetate on the metabolism of glucose, pyruvate, acetate, 3-hydroxybutyrate and palmitate in rat diaphragm and heart muscle in vitro and on extractions of glucose, lactate, pyruvate and free fatty acids by dog heart in vivo. Biochem J 1973;134:1067-1081.
44. Nuutila P, Koivisto VA, Knuuti J, et al. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest 1992;89:1767-1774.
45. Neely JR, Morgan HE. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu Rev Physiol 1974;36:413-459.
46. Manchester J, Kong X, Nerbonne J, Lowry OH, Lawrence JC. Glucose transport and phosphorylation in single cardiac myocytesrate-limiting steps in glucose metabolism. Am J Physiol 1994;266:E326-E333.
47. Kashiwaya Y, Sato K, Tsuchiya N, et al. Control of glucose utilization in working perfused rat heart. J Biol Chem 1994;269:25502-25514.
48. Cushman SW, Wardzala LJ. Potential mechanism of insulin action on glucose transport in isolated rat adipose cells: apparent translocation of intracellular transport systems to the plasma membrane. J Biol Chem 1980;255:4758-4762.
49. Suzuki K, Kono T. Evidence that insulin causes the translocation of glucose transport activity to the plasma membrane from an intracellular storage site. Proc Natl Acad Sci USA 1980;77:2542-2545.
50. Barnard RJ, Youngren JF. Regulation of glucose transport in skeletal muscle. FASEB J 1992;6:3238-3244.
51. Gould GW, Holman GD. The glucose transporter family: structure, function and tissue-specific expression. Biochem J 1993;295:329-341.
52. Mueckler M. Facilitative glucose transporters. Eur J Biochem 1994;219:713-725.
53. Satoh S, Nishimura H, Clark AE, et al. Use of bismannose photolabel to elucidate insulin-regulated GLUT4 subcellular trafficking kinetics in rat adipose cells. J Biol Chem 1993;268:17820-17829.
54. Holman GD, Leggio LL, Cushman SW. Insulin-stimulated GLUT4 glucose transporter recycling: a problem in membrane protein subcellular trafficking through multiple pools. J Biol Chem 1994;269:17516-17524.
55. Watanabe T, Smith MM, Robinson FW, Kono T. Insulin action on glucose transport in cardiac muscle. J Biol Chem 1984;259:13117-13122.
56. Slot JW, Geuze HJ, Gigengack S, James DE, Lienhard GE. Translocation of the glucose transporter GLUT-4 in cardiac myocytes of the rat. Proc Natl Acad Sci USA 1991;88:7815-7819.
57. Uphues I, Kolter T, Goud B, Eckel J. Insulin-induced translocation of the glucose transporter GLUT4 in cardiac muscle: studies on the role of small-molecular-mass GTP-binding proteins. Biochem J 1994;301:177-182.
58. Russell RR, Yin R, Xiaoyue H, et al. Insulin stimulates translocation of both GLUT4 and GLUT1 in the heart. Circulation 1996;24(suppl I):I308. (Abstract 1794).
59. Rodnick KJ, Slot JW, Studelska DR, et al. Immunocytochemical and biochemical studies of GLUT4 in rat skeletal muscle. J Biol Chem 1992;267:6278-6285.
60. Burdett E, Beeler T, Klip A. Distribution of glucose transporters and insulin receptors in the plasma membrane and transverse tubules of skeletal muscle. Arch Biochem Biophys 1987;253:279-286.
61. Dohm GL, Dolan PL, Frisell WR, Dudek RW. Role of transverse tubules in insulin stimulated muscle glucose transport. J Cell Biochem 1993;52:1-7.
62. Rothman JE. Mechanisms of intracellular protein transport. Nature 1994;372:55-63.
63. Sudhof TC. The synaptic vesicle cycle: a cascade of protein-protein interactions. Nature 1995;375:645-653.
64. Cain CC, Trimble WS, Lienhard GE. Members of the VAMP family of synaptic vesicle proteins are components of glucose transporter-containing vesicles from rat adipocytes. J Biol Chem 1992;267:11681-11684.
65. Manchester J, Kong X, Lowry OH, Lawrence JC. Ras signaling in the activation of glucose transport by insulin. Proc Natl Acad Sci USA 1994;91:4644-4648.
66. James DE, Strube M, Mueckler M. Molecular cloning and characterization of an insulin-regulatable glucose transporter. Nature 1989;338:83-87.
67. Kraegen EW, Sowden JA, Halstead MB, et al. Glucose transporters and in vivo glucose uptake in skeletal and cardiac muscle: fasting, insulin stimulation and immunoisolation studies of GLUT1 and GLUT4. Biochem J 1993;295:287-293.
68. King PA, Hirshman ME, Horton ES, Horton ED. Glucose transport in skeletal muscle membrane vesicles from control and exercised rats. Am J Physiol 1984;257:C1128-C1134.
69. Hirshman ME, Wallberg-Henriksson H, Wardzala LJ, Horton ED, Horton ES. Acute exercise increases the number of plasma membrane glucose transporters in rat skeletal muscle. FEBS Lett 1988;238:235-239.
70. Kolter T, Uphues I, Wichelhaus A, Reinauer H, Eckel J. Contraction-induced translocation of the glucose transporter GLUT4 in isolated ventricular cardiomyocytes. Biochem Biophys Res Commun 1992;189:1207-1214.
71. 2+ to stimulate glucose transport and GLUT4 translocation in perfused rat heart. Biochim Biophys Acta 1991;1094:217-223.
72. Knowlton FP, Starling EH. Experiments on the consumption of sugar in the normal and the diabetic heart. J Physiol 1912;45:146-163.
73. Charron MJ, Kahn BB. Divergent molecular mechanisms for insulin-resistant glucose transport in muscle and adipose cells in vivo. J Biol Chem 1990;265:7994-8000.
74. Berger JC, Diswas C, Vicario P, Strout HV, Saperstein R, Pilch PF. Decreased expression of the insulin-responsive glucose transporter in diabetes and fasting. Nature 1989;340:70-72.
75. Garvey TW, Huecksteadt TP, Birnbaum MJ. Pretranslational suppression of an insulin-responsive glucose transporter in rats with diabetes mellitus. Science 1989;245:60-63.
76. Ramlal T, Rastogi S, Vranic M, Klip A. Decrease in glucose transporter number in skeletal muscle of mildly diabetic (streptozotocin-treated) rats. Endocrinology 1989;125:890-897.
77. Kahn BB, Rossetti L, Lodish HF, Charron MJ. Decreased in vivo glucose uptake but normal expression of GLUT1 and GLUT4 in skeletal muscle of diabetic rats. J Clin Invest 1991;87:2197-2206.
78. Burcelin R, Printz RL, Kande J, Assan R, Granner DK, Girard J. Regulation of glucose transporter and hexokinase II expression in tissues of diabete rats. Am J Physiol 1993;265:E392-E401.
79. Camps M, Castello A, Munoz P, et al. Effect of diabetes and fasting on GLUT-4 (muscle/fat) glucose-transporter expression in insulin-sensitive tissues. Biochem J 1992;282:765-772.
80. Nuutila P, Knuuti J, Ruotsalainen U, et al. Insulin resistance is localized to skeletal but not heart muscle in type 1 diabetes. Am J Physiol 1993;264:E756-E762.
81. Cruickshank EWH, Kosterlitz HW. The utilization of fat by the aglycaemic mammalian heart. J Physiol 1941;99:208-223.
82. Laughlin MR, Taylor JF, Chesnick AS, Balaban RS. Non-glucose substrates increase glycogen synthesis in vivo in dog heart. Am J Physiol 1994;267:H217-H223.
83. Judd WT, Poland JL. Myocardial glycogen changes with exercise. Proc Soc Exp Biol Med 1972;140:955-957.
84. Henning SL, Wambolt RB, Schonekess BO, Lopaschuk GD, Allard MF. Contribution of glycogen to aerobic myocardial glucose metabolism. Circulation 1996;93:1549-1555.
85. Goodwin GW, Arteaga JR, Taegtmeyer H. Glycogen turnover in the isolated working rat heart. J Biol Chem 1995;270:9234-9240.
86. Goodwin G, Ahmad F, Taegtmeyer H. Preferential oxidation of glycogen in isolated working rat heart. J Clin Invest 1996;97:1409-1416.
87. Lundsgaard-Hansen P, Meyer C, Riedwyl H. Transmural gradients of glycolytic enzymes in the ventricular myocardium. Pflügers Arch Ges Physiol 1967;297:89-106.
88. De Tata V, Bergamini C, Gori Z, Locci-Cubeddu T, Bergamini E. Transmural gradient of glycogen metabolism in the normal rat left ventricle. Pflugers Arch 1983;396:60-65.
89. Krebs EG. Protein phosphorylation and cellular regulation. Biosci Rep 1993;13:127-142.
90. Davis CH, Schliselfeld LH, Wolf DP, Leavitt CA, Krebs EG. Interrelationships among glycogen phosphorylase isozymes. J Biol Chem 1967;242:4824-4833.
91. Cooper RH, Sul HS, McCullough TE, Walsh DA. Purification and properties of the cardiac isozyme of phosphorylase kinase. J Biol Chem 1980;255:11794-11801.
92. Ramachandran C, Angelos KL, Walsh DA. Hormonal regulation of the phosphorylation of glycogen synthase in perfused rat heart. Effects of insulin, catecholamines and glucagon. J Biol Chem 1983;258:13377-13383.
93. Roach PJ. Control of glycogen synthase by hierarchical protein phosphorylation. FASEB J 1990;4:2961-2967.
94. Grekinis D, Reimann EM, Schlender KK. Phosphorylation and inactivation of rat heart glycogen synthase by cAMP-dependent and cAMP-independent protein kinases. Int J Biochem 1995;27:565-573.
95. Chain EB, Mansford KRL, Opie LH. Effects of insulin on the pattern of glucose metabolism in the perfused working and Langendorff heart of normal and insulin-deficient rats. Biochem J 1969;115:537-552.
96. Adolfsson S, Isaksson O, Hjalmarson A. Effect of insulin on glycogen synthesis and synthetase activity in the perfused rat heart. Biochim Biophys Acta 1972;279:146-156.
97. Laughlin MR, Taylor JF, Chesnick AS, Balaban RS. Regulation of glycogen metabolism in canine myocardium: effects of insulin and epinephrine in vivo. Am J Physiol 1992;262:E875-E883.
98. Miller TB. A dual role for insulin in the regulation of cardiac glycogen synthase. J Biol Chem 1978;253:5389-5394.
99. Miller TB. Altered regulation of cardiac metabolism in sponta-neously diabetic rats. Am J Physiol 1983;245:E379-E383.
100. Nuttall FQ, Gannon MC, Corbett VA, Wheeler MP. Insulin stimulation of glycogen synthase D phosphatase (protein phosphatase). J Biol Chem 1976;251:6724-6729.
101. Laughlin MR, Petit WA, Shulman RG, Barrett EJ. Measurement of myocardial glycogen synthesis in diabetic and fasted rats. Am J Physiol 1990;258:E184-E190.
102. Thorburn AW, Gumbiner B, Bulacan F, Brechtel G, Henry RR. Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin dependent diabetes mellitus. J Clin Invest 1991;87:489-495.
103. Buczek-Thomas JA, Miller TB. Identification of the molecular basis for phosphorylase hypersensitivity in cultured diabetic cardiomyocytes. Mol Cell Biochem 1995;145:131-139.
104. Linn TC, Pettit FH, Reed LJ. Regulation of the activity of the pyruvate dehydrogenase complex from beef kidney mitochondria by phosphorylation and dephosphorylation. Proc Natl Acad Sci USA 1969;62:234-241.
105. Garland PB, Randle PJ. Control of pyruvate dehydrogenase in perfused rat heart by intracellular concentrations of acetyl CoA. Biochem J 1964;91:6C-7C.
106. Cooper RH, Randle PJ, Denton RM. Regulation of heart muscle pyruvate dehydrogenase kinase. Biochem J 1974;143:625-641.
107. Whitehouse S, Cooper RH, Randle PJ. Mechanism of activation of pyruvate dehydrogenase by dichloroacetate and other halogenated carboxylic acids. Biochem J 1974;141:761-774.
108. Martin BR, Denton RM, Randle PJ. Stimulation by calcium ions of pyruvate dehydrogenase phosphate phosphatase. Biochem J 1972;128:161-163.
109. 2+ in the regulation of oxidative phosphorylation in mammalian tissues. Biochem Soc Trans 1993;21:793-799.
110. i into pyruvate dehydrogenase phosphate in mitochondria from control and insulin-treated adipose tissue. Nature 1976;264:471-473.
111. Severson DL, Denton RM, Pask HT, Randle PJ. Calcium and magnesium ions as effectors of adipose tissue pyruvate dehydrogenase phosphate phosphatase. Biochem J 1974;140:225-237.
112. McCormack GJ, England PJ. Ruthenium red inhibits the activation of pyruvate dehydrogenase caused by positive inotropic agents in the perfused heart. Biochem J 1983;214:581-585.
113. Midgley PJW, Rutter GA, Thomas AP, Denton RM. Effects of calcium and magnesium on the activity of pyruvate dehydrogenase phosphate phosphatase within toluene-permeabilized mitochondria. Biochem J 1987;241:371-377.
114. Rutter GA, Diggle TA, Denton RM. Regulation of pyruvate dehydrogenase by insulin and polyamines within electropermeabilized fat-cells and isolated mitochondria. Biochem J 1992;285:435-439.
115. McCormack GJ, Halestrap AP, Denton RM. Role of calcium ions in regulation of mammalian intramitochondrial metabolism. Physiol Rev 1990;70:391-425.
116. Priestman DA, Mistry SC, Halsall A, Randle PJ. Role of protein synthesis and of fatty acid metabolism in the longer-term regulation of pyruvate dehydrogenase kinase. Biochem J 1994;300:659-664.
117. Jones BS, Yeaman SJ. Long-term regulation of pyruvate dehydrogenase complex. Evidence that kinase activator protein (KAP) is free pyruvate dehydrogenase kinase. Biochem J 1991;275:780-783.
118. Morgan HE, Henderson MJ, Regen DM, Park CR. Regulation of glucose uptake in muscle. I. The effects of insulin and anoxia on glucose transport and phosphorylation in the isolated perfused heart of normal rats. J Biol Chem 1961;236:253-261.
119. Hue L, Depre C, Lefebvre V, Rider MH, Veitch K. Regulation of glucose metabolism in cardiac muscle. Biochem Soc Trans 1995;23:311-314.
120. Kurland IJ, Pilkis SJ. Covalent control of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: insights into autoregulation of a bifunctional enzyme. Protein Sci 1995;4:1023-1037.
121. Lawson JWR, Uyeda K. Effects of insulin and work on fructose 2,6-bisphosphate content and phosphofructokinase activity in perfused rat hearts. J Biol Chem 1987;262:3165-3173.
122. Rider MH, Foret D, Hue L. Comparison of purified bovine heart and rat liver 6-phosphofructo-2-kinase. Biochem J 1985;231:193-196.
123. Pilkis SJ, Claus TH. Hepatic gluconeogenesis/glycolysis: regulation and structure/function relationships of substrate cycle enzymes. Annu Rev Nutr 1991;11:465-515.
124. Randle PJ, England PJ, Denton RM. Control of the tricarboxylate cycle and its interactions with glycolysis during acetate utilization in the heart. Biochem J 1970;117:677-695.
125. Colowick SP, Cori GT, Slein MW. The effect of adrenal cortex and anterior pituitary extracts and insulin on the hexokinase reaction. J Biol Chem 1947;168:583-596.
126. Sochor M, Gonzalez A-M, McLean P. Regulation of alternative pathways of glucose metabolism in rat heart by alloxan diabetes: changes in pentose phosphate pathway. Biochem Biophys Res Commun 1984;118:110-116.
127. Printz RL, Koch S, Potter LR, et al. Hexokinase II mRNA and gene structure, regulation by insulin and evolution. J Biol Chem 1993;268:5209-5219.
128. Olson RE, Hoeschen RJ. Utilization of endogenous lipid by the isolated perfused rat heart. Biochem J 1967;108:796-801.
129. Evans JR, Opie LH, Renold AE. Pyruvate metabolism in the perfused rat heart. Am J Physiol 1963;205:971-976.
130. Saddik M, Lopaschuk GD. Myocardial triacylglycerol turnover and contribution to energy substrate utilization in isolated working rat hearts. J Biol Chem 1991;266:8162-8170.
131. Taskinen M-R. Lipoprotein lipase in diabetes. Diabetes Metab Rev 1987;3:551-570.
132. Olivecrona G, Olivecrona T. Triglyceride lipases and atherosclerosis. Curr Opin Lipidol 1995;6:291-305.
133. O'Looney P, Vander Maten M, Vahouny GV. Insulin-mediated modification of myocardial lipoprotein lipase and lipoprotein metabolism. J Biol Chem 1983;258:12994-13001.
134. O'Looney P, Irwin D, Briscoe P, Vahouny GV. Lipoprotein composition as a component in the lipoprotein clearance defect in experimental diabetes. J Biol Chem 1985;260:428-432.
135. Braun JEA, Severson DL. Diabetes reduces the heparin- and phospholipase C-releasable lipoprotein lipase from cardiomyocytes. Am J Physiol 1991;260:E477-E485.
136. Carroll R, Liu L, Severson DL. Post-transcriptional mechanisms are responsible for the reduction in lipoprotein lipase activity in cardiomyocytes from diabetic rat hearts. Biochem J 1995;310:67-72.
137. Fisher RB, Williamson JR. The effects of insulin, adrenaline and nutrients on the oxygen uptake of the perfused rat heart. J Physiol 1961;158:102-112.
138. Denton RM, Randle PJ. Hormonal control of lipid concentration in rat heart and gastrocnemius. Nature 1965;208:488.
139. Garland PB, Randle PJ. Regulation of glucose uptake by muscle. 10. Effects of alloxan-diabetes, starvation, hypophysectomy and adrenalectomy, and of fatty acids, ketone bodies and pyruvate on the glycerol output and concentrations of free fatty acids, long-chain fatty acyl-CoA, glycerol phosphate and citrate-cycle intermediates in rat heart and diaphragm muscles. Biochem J 1964;93:678-687.
140. Saddik M, Lopaschuk GD. Triacylglycerol turnover in isolated working hearts of acutely diabetic rats. Can J Physiol Pharmacol 1994;72:1110-1119.
141. Kreisberg RA. Effect of epinephrine on myocardial triglyceride and free fatty acid utilization. Am J Physiol 1966;210:385-389.
142. Brownsey RW, Brunt RV. The effect of adrenaline-induced endogenous lipolysis upon the mechanical and metabolic performance of ischaemically-perfused rat hearts. Clin Sci Mol Med 1977;53:513-521.
143. Crass MF, Shipp JC, Pieper GM. Effects of catecholamines on myocardial endogenous substrates and contractility. Am J Physiol 1975;228:618-627.
144. Small CA, Garton AJ, Yeaman SJ. The presence and role of hormone-sensitive lipase in heart muscle. Biochem J 1989;258:67-72.
145. Severson DL. Regulation of lipid metabolism in adipose tissue and heart. Can J Physiol Pharmacol 1979;57:923-937.
146. Stralfors P, Bjorgell P, Belfrage P. Hormonal regulation of hormone-sensitive lipase in intact adipocytes: identification of phosphorylated sites and effects on the phosphorylation by lipolytic hormones and insulin. Proc Natl Acad Sci USA 1984;81:3317-3321.
147. Crass MF. Exogenous substrate effects on endogenous lipid metabolism in the working rat heart. Biochim Biophys Acta 1972;280:71-81.
148. Denton RM, Randle PJ. Concentrations of glycerides and phospholipids in rat heart and gastrocnemius muscles. Effects of alloxan-diabetes and perfusion. Biochem J 1967;104:416-422.
149. McGarry JD, Mannaerts GP, Foster DW. A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis. J Clin Invest 1977;60:265-270.
150. Weis BC, Cowan AT, Brown N, Foster DW, McGarry JD. Use of a selective inhibitor of liver carnitine palmitoyltransferase I (CPT I) allows quantification of its contribution to total CPT I activity in rat heart. J Biol Chem 1994;269:26443-26448.
151. McGarry JD, Mills SE, Long CS, Foster DW. Observations on the affinity of carnitine, and malonyl-CoA sensitivity of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat. Biochem J 1983;214:21-28.
152. i values. J Biol Chem 1984;259:12030-12033.
153. i values for malonyl-CoA. J Biol Chem 1987;262:2050-2055.
154. Hudson EK, Liu M-H, Buja LM, McMillin JB. Insulin-associated changes in carnitine palmitoyltransferase in cultured neonatal rat cardiac myocytes. J Mol Cell Cardiol 1995;27:599-613.
155. Brownsey RW, Denton RM. Acetyl CoA carboxylase. In: Boyer P, Krebs EG, eds. The Enzymes, 3rd edn. Control by Phosphorylation, Part B. New York: Academic Press, 1987;XVIII:123-146.
156. Thampy KG. Formation of malonyl-CoA in rat heart. J Biol Chem 1989;264:17631-17634.
157. Bianchi A, Evans JL, Iverson AJ, Nordlund AC, Watts TD, Witters LA. Identification of an isozymic form of acetyl-CoA carboxylase. J Biol Chem 1990;265:1502-1509.
158. Saddik M, Gamble J, Witters LA, Lopaschuk GD. Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. J Biol Chem 1993;268:25836-25845.
159. Winz R, Hess D, Aebersold R, Brownsey RW. Unique structural features and differential phosphorylation of the 280-kDa component (isozyme) of rat liver acetyl-CoA carboxylase. J Biol Chem 1994;269:14438-14445.
160. Lopaschuk GD, Gamble J. Acetyl-CoA carboxylase: an important regulator of fatty acid oxidation in the heart. Can J Physiol Pharmacol 1994;72:1101-1109.
161. Hardie DG. Regulation of fatty acid synthesis via phosphorylation of acetyl-CoA carboxylase. Prog Lipid Res 1989;28:117-146.
162. Kim K-H, Lopez-Casillas F, Bai DH, Luo X, Pape ME. Role of reversible phosphorylation of acetyl-CoA carboxylase in long-chain fatty acid synthesis. FASEB J 1989;3:2250-2256.
163. Brownsey RW, Hughes WA, Denton RM. Adrenaline and the regulation of acetyl-CoA carboxylase in rat epididymal adipose tissue: inactivation of the enzyme is associated with phosphorylation and can be reversed upon dephosphorylation. Biochem J 1979;184:23-32.
164. Witters LA, Moriarty D, Martin DB. Regulation of hepatic acetyl-CoA carboxylase by insulin and glucagon. J Biol Chem 1979;254:6644-6649.
165. Kudo N, Barr AJ, Barr RL, Desai S, Lopaschuk GD. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J Biol Chem 1995;270:17513-17520.
166. Anwan MM, Saggerson DE. Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation. Biochem J 1993;295:61-65.
167. 2 formed from endogenous and exogenous substrates in perfused rat heart. Am J Physiol 1964;207:1231-1236.
168. Kim YS, Kolattukudy PE. Purification and properties of malonyl-CoA decarboxylase from rat liver mitochondria and its immunological comparison with the enzymes from rat brain, heart and mammary gland. Arch Biochem Biophys 1978;190:234-246.
169. Barrn RL, Kozak R, Lopaschuk GD. Malonyl CoA degradation in the reperfused heart. Circulation 1996;44:I-12. (Abstract).
170. Tavare JM, Siddle K. Mutational analysis of insulin receptor function. Consensus and controversy. Biochim Biophys Acta 1993;1178:21-39.
171. Ullrich A, Bell JR, Chen EY, et al. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 1985;313:756-761.
172. Ebina Y, Ellis L, Jarnagin K, et al. The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell 1985;40:747-758.
173. De Meyts P. The structural basis of insulin and insulin-like growth factor-I receptor binding and negative co-operativity, and its relevance to mitogenic versus metabolic signalling. Diabetologia 1994;37:S135-S148.
174. Andersen AS, Kjeldsen T, Wiberg FC, et al. Identification of determinants that confer ligand specificity on the insulin receptor. J Biol Chem 1992;267:13681-13686.
175. Mynarcik DC, Yu GQ, Whittaker J. Alanine-scanning mutagenesis of a C-terminal ligand binding domain of the insulin receptor alpha-subunits. J Biol Chem 1996;271:2439-2442.
176. Mosthaf L, Gralko K, Dull TJ, Coussens L, Ullrich A, McClain DA. Functionally distinct insulin receptors generated by tissue-specific alternative splicing. EMBO J 1990;9:2409-2413.
177. Mosthaf L, Vogt B, Haring H-U, Ullrich A. Altered expression of insulin receptor types A and B in the skeletal muscle of non-insulin-dependent diabetes mellitus patients. Proc Natl Acad Sci USA 1991;88:4728-4730.
178. Kosaki A, Pillay TS, Xu L, Webster NJG. The B isoform of the insulin receptor signals more efficiently, than the A isoform in HepG2 cells. J Biol Chem 1995;270:20816-20823.
179. King GL, Johnson SM. Receptor-mediated transport of insulin across endothelial cells. Science 1985;227:1583-1586.
180. Bleehen NM, Fisher RB. The action of insulin in the isolated rat heart. J Physiol 1954;123:260-276.
181. Kono T, Barham FW. The relationship between the insulin-binding capacity of fat cells and the cellular response to insulin: studies with intact and trypsin-treated fat cells. J Biol Chem 1971;246:6210-6216.
182. Taylor SI. Lilly Lecture: Molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene. Diabetes 1992;41:1473-1490.
183. Wilden PA, Kahn CR, Siddle K, Whit F. Insulin receptor kinase domain autophosphorylation regulates receptor enzymatic function. J Biol Chem 1992;267:16660-16668.
184. Tornqvist HE, Pierce MW, Frackelton AR, Nemenoff RA, Avruch J. Identification of insulin receptor tyrosine residues autophospho-rylated in vitro. J Biol Chem 1987;262:10212-10219.
185. Wei L, Hubbard SR, Hendrickson WA, Ellis L. Expression, characterization, and crystallization of the catalytic core of the human insulin receptor protein-tyrosine kinase domain. J Biol Chem 1995;270:8122-8130.
186. Myers MG, Sun XJ, White MF. The IRS-1 signaling system. Trends Biochem Sci 1994;19:289-293.
187. r 185,000 protein in intact cells. Nature 1985;318:183-186.
188. Lee C-H, Li W, Nishimura R, et al. Nek associates with the SH2 domain-docking protein IRS-1 in insulin-stimulated cells. Proc Natl Acad Sci USA 1993;90:11713-11717.
189. Kuhn MR, Pawson T, Lienhard GE, Feng G-S. The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp. J Biol Chem 1993;268:11479-11481.
190. Yonezawa K, Ueda H, Hara K, et al. Insulin-dependent formation of a complex containing an 85-kDa subunit of phosphatidylinositol 3-kinase and tyrosine-phosphorylated insulin receptor substrate 1. J Biol Chem 1992;267:25958-25966.
191. Tamemoto H, Kadowaki T, Tobe K, et al. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 1994;372:182-186.
192. Wang LH, Hayashi H, Mitani Y, et al. Cloning of a cDNA encoding a 190-kDa insulin receptor substrate-1-like protein of simian COS cells. Biochem Biophys Res Commun 1995;216:321-328.
193. Sun XJ, Wang LM, Zhang Y, et al. Role of IRS-2 in insulin and cytokine signalling. Nature 1995;377:173-177.
194. Kovacina KS, Roth RA. Identification of SHC as a substrate of the insulin receptor kinase distinct from the GAP-associated 62 kDa tyrosine phosphoprotein. Biochem Biophys Res Commun 1993;192:1303-1311.
195. Okada S, Yamauchi K, Pessin JE. She isoform-specific tyrosine phosphorylation by the insulin and epidermal growth factor receptors. J Biol Chem 1995;270:20737-20741.
196. Hansen H, Svensson U, Zhu JW, et al. Interaction between the Grb10 SH2 domain and the insulin receptor carboxyl terminus. J Biol Chem 1996;271:8882-8886.
197. Bonfini L, Migliaccio E, Pelicci G, Lanfrancone L, Pelicci P. Not all She's roads lead to Ras. Trends Biochem Sci 1996;21:257-261.
198. Levy-Toledano R, Taouis M, Blaettler DH, Gorden P, Taylor SI.
199. Staubs PA, Reichart DR, Saltiel AR, et al. Localization of the insulin receptor binding sites for the SH2 domain proteins p85, Syp, and GAP. J Biol Chem 1994;269:27186-27192.
200. Okada T, Kawano Y, Sakakibara T, Hazeki O, Ui M. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. J Biol Chem 1994;269:3568-3573.
201. Hara K, Yonezawa K, Sakaue H, et al. Normal activation of p70 S6 kinase by insulin in cells overexpressing dominant negative 85kD subunit of phosphoinositide 3-kinase. Biochem Biophys Res Commun 1995;208:735-741.
202. Moule SK, Edgell NJ, Welsh GI, et al. Multiple signalling pathways involved in the stimulation of fatty acid and glycogen synthesis by insulin in rat epididymal fat cells. Biochem J 1995;311:595-601.
203. Nakanishi H, Brewer KA, Exton JH. Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 1993;268:13-16.
204. Kohn AD, Kovacina KS, Roth RA. Insulin stimulates the kinase activity of RAC-PK, a pleckstrin homology domain containing ser/thr kinase. EMBO J 1995;14:4288-4295.
205. Cross DAE, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995;378:785-789.
206. Kohn AD, Takeuchi F, Roth RA. Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation. J Biol Chem 1996;271:21920-21926.
207. 2+. Biochim Biophys Acta 1995;1267:139-144.
208. Kohn, A.D., Summers, S.A., Birnbaum, M.J., Roth, R.A. Expression of a constitutively active akt ser/thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and GLUT4 translocation. J. Biol. Chem. 1996 (in press).
209. Sasaoka T, Draznin B, Leitner JW, Langlois WJ, Olefsky JM. She is the predominant signaling molecule coupling insulin receptors to activation of guanine nucleotide releasing factor and p21ras-GTP formation. J Biol Chem 1994;269:10734-10738.
210. Pronk GJ, McGlade J, Pelicci G, Pawson T, Bos JL. Insulin-induced phosphorylation of the 46- and 52-kDa She proteins. J Biol Chem 1993;268:5748-5753.
211. Chardin P, Camonis JH, Gale NW, et al. Human Sos1A guanine nucleotide exchange factor for Ras that binds to GRB2. Science 1993;260:1338-1343.
212. Davis RJ. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 1993;268:14553-14556.
213. Seger R, Krebs EG. The MAP kinase signaling cascade. FASEB J 1995;9:726-735.
214. Ray LB, Sturgill TW. Rapid stimulation by insulin of a serine/threonine kinase in 3T3-L1 adipocytes that phosphorylates microtubule-associated protein-2 in vitro. Proc Natl Acad Sci USA 1987;84:1502-1506.
215. Warne PH, Viciana PR, Downward J. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro. Nature 1993;364:352-355.
216. Russell M, Lange-Carter CA, Johnson GL. Direct interaction between Ras and the kinase domain of mitogen-activated protein kinase kinase kinase (MEKK1). J Biol Chem 1995;270:11757-11760.
217. Kikuchi A, Williams LT. The post-translational modification of ras p21 is important for Raf-1 activation. J Biol Chem 1994;269:20054-20059.
218. Farrar MA, Alberola-Ila J, Perlmutter RM. Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization. Nature 1996;383:178-181.
219. Luo Z, Tzivion G, Belshaw PJ, Vavvas D, Marshall M, Avruch J. Oligomerization activates c-Raf-1 through a Ras-dependent mechanism. Nature 1996;383:181-185.
220. Huang W, Alessandrini A, Crews CM, Erikson RL. Raf-1 forms a stable complex with Mek1 and activates Mek1 by serine phosphorylation. Proc Natl Acad Sci USA 1993;90:10947-10951.
221. Crews CM, Erikson. Extracellular signals and reversible protein phosphorylation: What to Mek of it all?. Cell 1993;74:215-217.
222. Page C, Doubell AF. Mitogen-activated protein kinase (MAPK) in cardiac tissues. Mol Cell Biochem 1996;157:49-57.
223. Sugden PH, Bogoyevitch MA. Intracellular signalling through protein kinases in the heart. Cardiovasc Res 1995;30:478-492.
224. Sturgill TW, Ray LB, Erikson E, Maller JL. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature 1988;334:715-718.
225. Welsh GI, Foulstone EJ, Young SW, Tavare JM, Proud CG. Wortmannin inhibits the effects of insulin and serum on the activities of glycogen synthase kinase-3 and mitogen-activated protein kinase. Biochem J 1994;303:15-20.
226. Cross DAE, Alessi DR, Vandenheede JR, McDowell HE, Cohen P. The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor I in the rat skeletal muscle cell line L6 is blocked by wortmannin but not by rapamycin. Evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf. Biochem J 1994;303:21-26.
227. Denton RM, Tavare JM. Does mitogen-activated-protein kinase have a role in insulin action? The cases for and against. Eur J Biochem 1995;227:597-611.
228. Robinson LJ, Razzack ZF, Lawrence JC. Jr, James, D.E. Mitogen-activated protein kinase activation is not sufficient for stimulation of glucose transport or glycogen synthase in 3T3-L1 adipocytes. J Biol Chem 1993;268:26422-26427.
229. Ohmichi M, Pang L, Ribon V, Saltiel AR. Divergence of signaling pathways for insulin in PC-12 pheochromocytoma cells. Endocrinology 1993;133:46-56.
230. Zhande R, Brownsey RW. Cell volume and the metabolic actions of insulin. Biochem Cell Biol 1996;74:513-522.
231. Apiazu I, Saltiel AR, DePaoli-Roach AA, Lawrence JC Jr.. Regulation of both glycogen synthase and PHAS-I by insulin in rat skeletal muscle involves mitogen-activated protein kinase-independent and rapamycin-sensitive pathways. J Biol Chem 1996;271:5033-5039.
232. Lazar DF, Wiese RJ, Brady MJ, et al. Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin. J Biol Chem 1995;270:20801-20807.
233. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 1995;270:16483-16486.
234. O'Brien RM, Granner DK. Regulation of gene expression by insulin. Biochem J 1991;278:609-619.
235. TCF by MAP kinase stimulates ternary complex formation by c-fos promoter. Nature 1992;358:414-417.
236. Xing J, Ginty DD, Greenberg ME. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 1996;273:959-963.
237. Ceresa BP, Pessin JE. Insulin stimulates the serine phosphorylation of the signal transducer and activator of transcription (STAT3) isoform. J Biol Chem 1996;271:12121-12124.
238. Redpath NT, Proud CG. Molecular mechanisms in the control of translation by hormones and growth factors. Biochim Biophys Acta 1994;1220:147-162.
239. Flotow H, Thomas G. Substrate recognition determinants of the mitogen-activated 70K S6 kinase from rat liver. J Biol Chem 1992;267:3074-3078.
240. Morley SJ, Traugh JA. Differential stimulation of phosphorylation of initiation factors eIF-4F, eIF-4B and eIF-3, and ribosomal protein S6 by insulin and phorbol esters. J Biol Chem 1990;265:10611-10616.
241. Lopaschuk GD, Spafford MA. Energy substrate utilization by isolated working hearts from newborn rabbits. Am J Physiol 1990;258:H1274-H1280.
242. Keller A, Rouzeau J-D, Farhadian F, et al. Differential expression of alpha- and beta-enolase genes during rat heart development and hypertrophy. Am J Physiol 1995;269:H1843-H1851.
243. Defronzo RA. Glucose intolerance and aging. Diabetes Care 1981;4:493-501.
244. Sims EAH, Danford E, Horton ES, Bray GA, Glennon JA, Salans LB. Endocrine and metabolic effects of experimental obesity in man. Recent Prog Hormone Res 1973;29:457-496.
245. Defronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diab Care 1991;14:173-194.
246. Ferrannini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med 1987;317:350-357.
247. Paternostro G, Clarke K, Heath J, Seymour A-ML, Radda GK. Decreased GLUT4 mRNA content and insulin-sensitive deoxyglucose uptake show insulin resistance in hypertensive rat heart. Cardiovasc Res 1995;30:205-211.
248. Regan TJ, Lyons MM, Ahmad SS, et al. Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest 1977;60:885-899.
249. Hamby RI, Zoneraich S, Sherman L. Diabetic cardiomyopathy. J Am Med Assoc 1974;229:1749-1754.
250. Nuutila P, Maki M, Laine H, et al. Insulin action on heart and skeletal muscle glucose uptake in essential hypertension. J Clin Invest 1995;96:1003-1009.
251. 31P-NMR spectroscopic study. Circulation 1995;92:1274-1283.
252. Weinberg EO, Thienelt CD, Lorell BH. Pretranslational regulation of glucose transporter isoform expression in hearts with pressure-overload left ventricular hypertrophy. Circulation 1995;92:I-365. (Abstract).
253. Allard MF, Flint JDA, English JC, et al. Calcium overload during reperfusion is accelerated in isolated hypertrophied rat hearts. J Mol Cell Cardiol 1994;26:1551-1563.
254. Schönekess BO, Allard MF, Lopaschuk GD. Propionyl L-carnitine improvement of hypertrophied heart function is accompanied by an increase in carbohydrate oxidation. Circ Res 1995;77:726-734.
255. Schönekess BO, Allard MF, Lopaschuk GD. Recovery of glycolysis and oxidative metabolism during postischemic reperfusion of hypertrophied rat hearts. Am J Physiol 1996;271:H798-H805.
256. Taegtmeyer H, Overturf ML. Effects of moderate hypertension on cardiac function and metabolism in the rabbit. Hypertension 1988;11:416-426.
257. Bishop SP, Aultschuld RA. Evidence for increased glycolytic metabolism in cardiac hypertrophy and congestive heart failure. In: Alpert N, ed. Cardiac Hypertrophy. New York: Academic Press, 1971:567-585.
258. Flaim KE, Kochel PJ, Kira Y, et al. Insulin effects on protein synthesis are independent of glucose and energy metabolism. Am J Physiol 1983;245:C133-C143.
259. Yu JZ, Bondy GP, Allard MF, et al. Serum from patients with chronic renal insufficiency alters growth characteristics and ANP mRNA expression of adult rat cardiac myocytes. J Mol Cell Cardiol 1996;in press.
260. Katz EB, Stenbit AE, Hatton K, DePinho R, Charron MJ. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature 1995;377:151-155.
261. Sadoshima J, Izumo S. Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro. Potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy. Circ Res 1995;77:1040-1052.
262. Price DJ, Grove JR, Calvo V, Avruch J, Bierer BE. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. Science 1992;257:973-977.
263. Saad MJA, Velloso LA, Carvalho CRO. Angiotensin II induces tyrosine phosphorylation of insulin receptor substrate 1 and its association with phosphatidylinositol 3-kinase in rat heart. Biochem J 1995;310:741-744.